401 related articles for article (PubMed ID: 34948271)
1. The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip.
Rahman S; Ghiboub M; Donkers JM; van de Steeg E; van Tol EAF; Hakvoort TBM; de Jonge WJ
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948271
[TBL] [Abstract][Full Text] [Related]
2. Human intestinal models to study interactions between intestine and microbes.
Aguilar-Rojas A; Olivo-Marin JC; Guillen N
Open Biol; 2020 Oct; 10(10):200199. PubMed ID: 33081633
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota derived metabolites contribute to intestinal barrier maturation at the suckling-to-weaning transition.
Beaumont M; Paës C; Mussard E; Knudsen C; Cauquil L; Aymard P; Barilly C; Gabinaud B; Zemb O; Fourre S; Gautier R; Lencina C; Eutamène H; Theodorou V; Canlet C; Combes S
Gut Microbes; 2020 Sep; 11(5):1268-1286. PubMed ID: 32352849
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
[TBL] [Abstract][Full Text] [Related]
5. Human intestinal organoids: Modeling gastrointestinal physiology and immunopathology - current applications and limitations.
Flood P; Hanrahan N; Nally K; Melgar S
Eur J Immunol; 2024 Feb; 54(2):e2250248. PubMed ID: 37957831
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Intestinal Trans-Epithelial Permeability.
Allam-Ndoul B; Castonguay-Paradis S; Veilleux A
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899147
[TBL] [Abstract][Full Text] [Related]
7. A higher throughput and physiologically relevant two-compartmental human ex vivo intestinal tissue system for studying gastrointestinal processes.
Stevens LJ; van Lipzig MMH; Erpelinck SLA; Pronk A; van Gorp J; Wortelboer HM; van de Steeg E
Eur J Pharm Sci; 2019 Sep; 137():104989. PubMed ID: 31301485
[TBL] [Abstract][Full Text] [Related]
8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Morphogenesis in Canine Gut-on-a-Chip Using Intestinal Organoids Derived from Inflammatory Bowel Disease Patients.
Nagao I; Nakazawa M; Ambrosini YM
J Vis Exp; 2024 Feb; (204):. PubMed ID: 38407238
[TBL] [Abstract][Full Text] [Related]
10. Potential Application of Intestinal Organoids in Intestinal Diseases.
Liu W; Wang Q; Bai Y; Xiao H; Li Z; Wang Y; Wang Q; Yang J; Sun H
Stem Cell Rev Rep; 2024 Jan; 20(1):124-137. PubMed ID: 37938407
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
[TBL] [Abstract][Full Text] [Related]
13. Immunocompetent Human Intestinal Models in Preclinical Drug Development.
Weindl G
Handb Exp Pharmacol; 2021; 265():219-233. PubMed ID: 33349897
[TBL] [Abstract][Full Text] [Related]
14. Development of a human primary gut-on-a-chip to model inflammatory processes.
Beaurivage C; Kanapeckaite A; Loomans C; Erdmann KS; Stallen J; Janssen RAJ
Sci Rep; 2020 Dec; 10(1):21475. PubMed ID: 33293676
[TBL] [Abstract][Full Text] [Related]
15. In vitro models and ex vivo systems used in inflammatory bowel disease.
Joshi A; Soni A; Acharya S
In Vitro Model; 2022; 1(3):213-227. PubMed ID: 37519330
[TBL] [Abstract][Full Text] [Related]
16. Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality.
Kulkarni G; Apostolou A; Ewart L; Lucchesi C; Kasendra M
J Vis Exp; 2022 May; (183):. PubMed ID: 35604153
[TBL] [Abstract][Full Text] [Related]
17. Organoids and organs-on-chips: Insights into human gut-microbe interactions.
Puschhof J; Pleguezuelos-Manzano C; Clevers H
Cell Host Microbe; 2021 Jun; 29(6):867-878. PubMed ID: 34111395
[TBL] [Abstract][Full Text] [Related]
18. Gut organoids: mini-tissues in culture to study intestinal physiology and disease.
Almeqdadi M; Mana MD; Roper J; Yilmaz ÖH
Am J Physiol Cell Physiol; 2019 Sep; 317(3):C405-C419. PubMed ID: 31216420
[TBL] [Abstract][Full Text] [Related]
19. Put Some Guts into It: Intestinal Organoid Models to Study Viral Infection.
García-Rodríguez I; Sridhar A; Pajkrt D; Wolthers KC
Viruses; 2020 Nov; 12(11):. PubMed ID: 33187072
[TBL] [Abstract][Full Text] [Related]
20. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.
Usuda H; Okamoto T; Wada K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
